Hypoglycemia awareness and its clinical implications in insulin-treated patients
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250066Keywords:
Hypoglycemia, IAH, , Type 2 diabetes mellitus, Clinical implicationsAbstract
Hypoglycemia is a significant complication of diabetes treatment. If left untreated, serious complications may occur. Mild hypoglycemia occurs in approximately 30% to 40% of those with insulin-treated type 2 diabetes. Overall prevalence of severe hypoglycemia in insulin-treated type 2 diabetes is 0.28 episodes per patient per year. Impaired awareness of hypoglycemia (IAH) is a possible complication of recurrent hypoglycemia episodes. Many prior studies have examined the prevalence of IAH in patients with type 1 diabetes, while there is limited data on the prevalence of IAH in insulin-treated type 2 diabetes. The following databases were used in systematic research: Medline (PubMed), Web of Science, and Scopus. Summaries of the found studies were exported by EndNoteX8, and duplicate studies were removed. Various mechanisms have been proposed in recent studies, such as the brain glucose transport hypothesis and the brain glycogen supercompensation hypothesis. It is important to assess the risk factors of IAH to avoid its significant complications. To successfully assess the risk factors, three methods of measuring are being used: Clarke, Gold, and Pedersen Bjergaard methods. The aim of this review is to discuss the prevalence, mechanisms, measurement, and clinical implications of IAH in insulin-treated type 2 diabetic patients.
Metrics
References
Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract. 2010;87(1):2-3. DOI: https://doi.org/10.1016/j.diabres.2009.11.006
Amiel SA. The consequences of hypoglycaemia. Diabetologia. 2021;64(5):963-70. DOI: https://doi.org/10.1007/s00125-020-05366-3
Frier BM. Hypoglycaemic valleys: an under-recognised problem in type 2 diabetes? Int J Clin Pract. 2002(129):12-9.
Gonzalez C, Monti C, Pinzon A, Monsanto H, Ejzykowicz F. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study. Endocrinologia, Diabetes y Nutricion. 2018;65(10):592-602. DOI: https://doi.org/10.1016/j.endinu.2018.05.014
Popoviciu S, Alionescu A, Sisic I. Prevalence of Hypoglycemia, Treatment Satisfaction, Adherence and Their Associations with Glycemic Goals in Patients with Type 2 Diabetes Mellitus Treated with Sulfonylureas: Findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) in Romania. Roman J Diabetes Nutr Metab Dis. 2019;26(1):55-64. DOI: https://doi.org/10.2478/rjdnmd-2019-0006
UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50(6):1140-7. DOI: https://doi.org/10.1007/s00125-007-0599-y
Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med. 2006;23(7):750-6. DOI: https://doi.org/10.1111/j.1464-5491.2006.01880.x
Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003;20(12):1016-21. DOI: https://doi.org/10.1046/j.1464-5491.2003.01072.x
Hendrieckx C, Hagger V, Jenkins A, Skinner TC, Pouwer F, Speight J. Severe hypoglycemia, impaired awareness of hypoglycemia, and self-monitoring in adults with type 1 diabetes: Results from Diabetes MILES-Australia. J Diabet Complications. 2017;31(3):577-82. DOI: https://doi.org/10.1016/j.jdiacomp.2016.11.013
Sakane N, Kato K, Hata S, Nishimura E, Araki R, Kouyama K, et al. Association of Impaired Awareness of Hypoglycemia with Driving Safety and Hypoglycemia Problem-solving Abilities among Patients with Type 1 Diabetes in Japan: The PR-IAH Study. Intern Med (Tokyo, Japan). 2023;62(10):1431-9. DOI: https://doi.org/10.2169/internalmedicine.0332-22
McNeilly AD, McCrimmon RJ. Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab. Diabetologia. 2018;61(4):743-50. DOI: https://doi.org/10.1007/s00125-018-4548-8
Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabet Res Clin Pract. 2010;87(1):64-8. DOI: https://doi.org/10.1016/j.diabres.2009.10.013
Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated Type 2 diabetes. Diabet Med. 2009;26(12):1306-8. DOI: https://doi.org/10.1111/j.1464-5491.2009.02834.x
Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697-703. DOI: https://doi.org/10.2337/diacare.17.7.697
Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18(4):517-22. DOI: https://doi.org/10.2337/diacare.18.4.517
Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet (London, England). 2001;357(9264):1248-53. DOI: https://doi.org/10.1016/S0140-6736(00)04405-6
Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Metzendorf MI, et al. Chapter 4: Searching for and selecting studies. Cochrane Training. Available at: https://training.cochrane. org/handbook/current/chapter-04. Accessed on 13 November 2024.
Martín-Timón I, Del Cañizo-Gómez FJ. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabet. 2015;6(7):912-26. DOI: https://doi.org/10.4239/wjd.v6.i7.912
Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes. 1994;43(12):1426-34. DOI: https://doi.org/10.2337/diabetes.43.12.1426
Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia. 1994;37(12):1265-76. DOI: https://doi.org/10.1007/BF00399801
Ramanathan R, Cryer PE. Adrenergic mediation of hypoglycemia-associated autonomic failure. Diabetes. 2011;60(2):602-6. DOI: https://doi.org/10.2337/db10-1374
Cranston I, Reed LJ, Marsden PK, Amiel SA. Changes in regional brain (18)F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes. 2001;50(10):2329-36. DOI: https://doi.org/10.2337/diabetes.50.10.2329
Dunn JT, Cranston I, Marsden PK, Amiel SA, Reed LJ. Attenuation of amydgala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in type 1 diabetes: a new player in hypoglycemia unawareness? Diabetes. 2007;56(11):2766-73. DOI: https://doi.org/10.2337/db07-0666
Mangia S, Tesfaye N, De Martino F, Kumar AF, Kollasch P, Moheet AA, et al. Hypoglycemia-induced increases in thalamic cerebral blood flow are blunted in subjects with type 1 diabetes and hypoglycemia unawareness. J Cereb Blood Flow Metab. 2012;32(11):2084-90. DOI: https://doi.org/10.1038/jcbfm.2012.117
Oz G, Kumar A, Rao JP, Kodl CT, Chow L, Eberly LE, et al. Human brain glycogen metabolism during and after hypoglycemia. Diabetes. 2009;58(9):1978-85. DOI: https://doi.org/10.2337/db09-0226
Canada SE, Weaver SA, Sharpe SN, Pederson BA. Brain glycogen supercompensation in the mouse after recovery from insulin-induced hypoglycemia. J Neurosci Res. 2011;89(4):585-91. DOI: https://doi.org/10.1002/jnr.22579
Öz G, Tesfaye N, Kumar A, Deelchand DK, Eberly LE, Seaquist ER. Brain glycogen content and metabolism in subjects with type 1 diabetes and hypoglycemia unawareness. J Cerebral Blood Flow Metab. 2012;32(2):256-63. DOI: https://doi.org/10.1038/jcbfm.2011.138
Ang LC, Bee YM, Goh SY, Teh MM. New insights into the currently available questionnaire for assessing impaired awareness of hypoglycaemia (IAH) among insulin-treated type 2 diabetes- A key risk factor for hypoglycaemia. Diabetes Epidemiol Manag. 2023;10:5.
Alkhatatbeh MJ, Abdalqader NA, Alqudah MAY. Impaired Awareness of Hypoglycaemia in Insulin-treated Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2019;15(5):407-13. DOI: https://doi.org/10.2174/1573399814666180806144937
van Meijel LA, de Vegt F, Abbink EJ, Rutters F, Schram MT, van der Klauw MM, et al. High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort. BMJ Open Diabetes Res Care. 2020;8(1):e000935. DOI: https://doi.org/10.1136/bmjdrc-2019-000935
Zhu L, Ang LC, Tan WB, Xin X, Bee YM, Goh SY, et al. A study to evaluate the prevalence of impaired awareness of hypoglycaemia in adults with type 2 diabetes in outpatient clinic in a tertiary care centre in Singapore. Ther Adv Endocrinol Metab. 2017;8(5):69-74. DOI: https://doi.org/10.1177/2042018817707422
Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2008;25(4):501-4. DOI: https://doi.org/10.1111/j.1464-5491.2008.02413.x
Ghandi K, Pieri B, Dornhorst A, Hussain S. A Comparison of Validated Methods Used to Assess Impaired Awareness of Hypoglycaemia in Type 1 Diabetes: An Observational Study. Diabetes Ther. 2021;12(1):441-51. DOI: https://doi.org/10.1007/s13300-020-00965-0
Sepúlveda E, Poínhos R, Nata G, Carvalho D, Neves JS, Seixas D, et al. Differentiating Hypoglycemia Awareness Status from Hypoglycemia Experience in Tools for Measuring Impaired Awareness of Hypoglycemia. Diabetes Technol Ther. 2020;22(7):541-5. DOI: https://doi.org/10.1089/dia.2020.0034
Geller AI, Shehab N, Lovegrove MC, Kegler SR, Weidenbach KN, Ryan GJ, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med. 2014;174(5):678-86. DOI: https://doi.org/10.1001/jamainternmed.2014.136
Olsen SE, Asvold BO, Frier BM, Aune SE, Hansen LI, Bjørgaas MR. Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with Type 1 diabetes: the association with diabetes duration. Diabet Med. 2014;31(10):1210-7. DOI: https://doi.org/10.1111/dme.12496
Ang LC, Bee YM, Goh SY, Teh MM. New Insights into the Currently Available Questionnaire for Assessing Impaired Awareness of Hypoglycaemia (IAH) Among Insulin-treated Type 2 Diabetes- A Key Risk Factor for Hypoglycaemia. Diabetes Epidemiol Manag. 2023;10:100136. DOI: https://doi.org/10.1016/j.deman.2023.100136
Cabré C, Colungo C, Vinagre I, Jansà M, Conget I. Frequency and awareness of hypoglycemia in patients with Type 2 Diabetes treated with two or more insulin injections in primary care outpatient clinics. Prim Care Diabet. 2020;14(2):168-72. DOI: https://doi.org/10.1016/j.pcd.2019.08.001
Cheng HJ, Weng SH, Wu JL, Yeh ST, Chen HF, Novida H, et al. Long-Term Sulfonylurea Use and Impaired Awareness of Hypoglycemia Among Patients With Type 2 Diabetes in Taiwan. Ann Fam Med. 2024;22(4):309-16. DOI: https://doi.org/10.1370/afm.3129
Gomez-Peralta F, Fornos Pérez JA, Molinero A, Sánchez Barrancos IM, Arranz Martínez E, Martínez-Pérez P, et al. Adherence to antidiabetic treatment and impaired hypoglycemia awareness in type 2 diabetes mellitus assessed in Spanish community pharmacies: the ADHIFAC study. BMJ Open Diabetes Res Care. 2021;9(2):e002148. DOI: https://doi.org/10.1136/bmjdrc-2021-002148
Ellis K, Mulnier H, Forbes A. Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis. BMC Fam Pract. 2018;19(1):70. DOI: https://doi.org/10.1186/s12875-018-0753-2
Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-59. DOI: https://doi.org/10.1056/NEJMoa0802743
Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33(6):1389-94. DOI: https://doi.org/10.2337/dc09-2082
Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care. 2003;26(5):1485-9. DOI: https://doi.org/10.2337/diacare.26.5.1485
Johnston SS, Conner C, Aagren M, Smith DM, Bouchard J, Brett J. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2011;34(5):1164-70. DOI: https://doi.org/10.2337/dc10-1915
Miller DR, Fincke G, Lafrance JP. Hypoglycaemia and risk of myocardial infarction in US veterans with diabetes. Diabetologia. 2009;52:S63.
Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP, Jr., Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565-72. DOI: https://doi.org/10.1001/jama.2009.460
Barendse S, Singh H, Frier BM, Speight J. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review. Diabet Med. 2012;29(3):293-302. DOI: https://doi.org/10.1111/j.1464-5491.2011.03416.x
Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin. 2005;21(9):1477-83. DOI: https://doi.org/10.1185/030079905X61929
Fidler C, Elmelund Christensen T, Gillard S. Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econom. 2011;14(5):646-55. DOI: https://doi.org/10.3111/13696998.2011.610852
Eadington DW, Frier BM. Type 1 diabetes and driving experience: an eight-year cohort study. Diabet Med. 1989;6(2):137-41. DOI: https://doi.org/10.1111/j.1464-5491.1989.tb02101.x
Lave LB, Songer TJ, LaPorte RE. Should persons with diabetes be licensed to drive trucks?--Risk management. Risk Analysis. 1993;13(3):327-34 DOI: https://doi.org/10.1111/j.1539-6924.1993.tb01084.x